Cel
Although the long term prognosis of patients suffering acute myocardial infarction (AMI) has improved since the introduction of reperfusion therapies and primary angioplasty, the 1 year mortality of patients with AMI and resultant left ventricular systolic dysfunction (LVSD) is still as high as 13%. A major reason for the high morbidity and mortality is that the heart has an inadequate regenerative response to the myocardial necrosis sustained following AMI; cell death from the ischaemic damage can lead to progressive ventricular dilation and dysfunction through the processes of vascular remodelling. Despite the use of full conventional treatment, including ACE inhibitors, beta-blockers, aldosterone inhibitors and diuretics, yearly mortality rates of patients with post-infarction heart failure are still in the range of 13 % and rehospitalisation for worsening of heart failure occurs at a yearly rate of 6–8%.
Clinical data now exists supporting the concept that autologous bone marrow derived cells can restore cardiac function following AMI. We plan to advance this research in the BAMI project and will:
• Develop a standardised method of bone marrow cell collection
• Develop a standardised method of optimising reparative potential of bone marrow derived cells
• Standardise bone marrow preparation procedure so that it can be universally applied
• Standardise method of bone marrow cell delivery post AMI
• Conduct the first large scale all-cause mortality clinical trial to test if the product and delivery method mentioned above can lead to a 25% reduction in mortality end-point at 2 years
Our project will establish the therapeutic value of this approach to stem cell therapy. Success will demonstrate that transcoronary infusion of bone marrow-derived progenitor cells is safe and will reduce the mortality rate by 25% and reduce the rehospitalisation rate by 15%.
Dziedzina nauki
Temat(-y)
Zaproszenie do składania wniosków
FP7-HEALTH-2011-two-stage
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-FP - Small or medium-scale focused research project
Koordynator
E1 4NS London
United Kingdom
Zobacz na mapie
Uczestnicy (21)
75012 Paris
Zobacz na mapie
3000 Leuven
Zobacz na mapie
Zakończenie uczestnictwa
60323 Frankfurt Am Main
08007 Barcelona
Zobacz na mapie
Zakończenie uczestnictwa
LN1 1XW Lincoln
WC1E 6BT London
Zobacz na mapie
60596 Frankfurt Am Main
Zobacz na mapie
9300 Aalst
Zobacz na mapie
30625 Hannover
Zobacz na mapie
625 00 Brno
Zobacz na mapie
3400 Hillerod
Zobacz na mapie
20123 Milano
Zobacz na mapie
SE5 9RS London
Zobacz na mapie
Zakończenie uczestnictwa
40 055 Katowice
Zakończenie uczestnictwa
18055 Rostock
1435 Mont Saint Guibert
Zobacz na mapie
70211 Kuopio
Zobacz na mapie
Zakończenie uczestnictwa
0450 Oslo
28020 Madrid
Zobacz na mapie
EX4 4QJ Exeter
Zobacz na mapie
60596 Frankfurt Am Main
Zobacz na mapie